Dr. Borchert is Chief Geneticist at GTR and Associate Professor of Pharmacology at the University of South Alabama College of Medicine. He received his Ph.D. in Interdisciplinary Genetics from the University of Iowa, followed by a postdoctoral fellowship at the University of California, Berkeley, where he worked under Dr. Jennifer Doudna, inventor of CRISPR-Cas9 gene editing technology. Dr. Borchert’s lab has published more than 25 articles in peer-reviewed journals and received numerous awards. In 2014, the Genetic Mechanisms Cluster of the National Science Foundation named Dr. Borchert a NSF CAREER Investigator - the most prestigious honor bestowed by the NSF.
Dr. Francis is Chief Science Officer at GT Research and Assistant Professor of Physiology and Cell Biology at the University of South Alabama College of Medicine and Center for Lung Biology. Dr. Francis is an experienced research scientist with extensive knowledge of genomics, biophysics, and computational analytics, receiving ~$1M in grant funding. Dr. Francis received a B.Sc in Physics from Auburn University and a PhD in Physiology from the University of South Alabama.
Peter McKinney is Chief Technology Officer at GTR, and oversees all technology-related initiative at the firm. He is an experienced full stack developer currently working in the microsoft .NET ecosystem with a specialization in Angular front-end development. Peter has worked previously as a software consultant primarily focused on automation of business processes through full stack development. He holds a Bachelor's Degree in Computer Science, with concentrations in AI, Linux System Administration, and Embedded Systems from the University of West Florida.
Sam is Founder and Chief Executive Officer of GTR. Sam was previously an attorney at Debevoise & Plimpton LLP in New York City, where he focused his practice on complex financial services regulation. Sam holds a JD from the University of Chicago Law School and a BSE from the Wharton School of the University of Pennsylvania, where he was a Benjamin Franklin Scholar and a Joseph Wharton Scholar.
Dr. Samaratunga is Chief Operating Officer at GTR. He completed his B.A. in Biological Sciences at the University of Pennsylvania, and a D.M.D. from the Boston University School of Dental Medicine, where he received the award for achievements in Biological Sciences in his graduating class.
Nick began his career in biology studying algae with the goal of monitoring water quality and ecosystem health of the wild waterways of California. His research interests focused mainly on gene regulation surrounding certain algae’s very complex life histories. In 2016, he transitioned into a consulting role for a number of entities which operate internationally in the health, sustainability, and green and novel technology spaces in the US, EU, Israel, and China. To date he has spearheaded many meaningful projects globally in the biomedical, pharmaceutical, environmental, agricultural technology, and policy arenas. This includes working closely with governments, funds, and companies in his areas of interest.